Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond (NASDAQ:CELC)

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?This is my first time initiating coverage of Celcuity Inc. ( CELC ) for Seeking Alpha. The Minneapolis based biotech raised a modest $26.2m in its September 2018 IPO, at a share price of $9.5, andEdmund Ingham is a ...